GSK ‘schemed’ FDA’s drug-device approval pathway to deflect asthma inhaler generics, lawsuit claims https://ift.tt/tD8AJzh fkansteiner via FiercePharma https://ift.tt/UnQKkiH May 25, 2022 at 01:51PM
Health plans can do more to improve price transparency for consumers, survey finds
Health plans can do more to improve price transparency for consumers, survey finds https://ift.tt/4D2C0tV agliadkovskaya via All Stories https://ift.tt/rbH1DNs May 25, 2022 at 01:47PM
Life sciences developer BioMed Realty buys San Francisco hotel for $75M — report
Life sciences developer BioMed Realty buys San Francisco hotel for $75M — report https://ift.tt/kQJbyPL Amber Tong via Endpoints https://endpts.com May 25, 2022 at 01:37PM
CareFirst BCBS, largest plan in mid-Atlantic, employs analytics firm to drive SDOH insights
CareFirst BCBS, largest plan in mid-Atlantic, employs analytics firm to drive SDOH insights https://ift.tt/BOlnQP2 agliadkovskaya via All Stories https://ift.tt/rbH1DNs May 25, 2022 at 01:35PM
AMA: Payers not following prior authorization reforms they agreed to in 2018
AMA: Payers not following prior authorization reforms they agreed to in 2018 https://ift.tt/or0xObM rking via All Stories https://ift.tt/rbH1DNs May 25, 2022 at 01:27PM
All about access: Pfizer moves to a non-profit model for drug sales in 45 lower-income countries
All about access: Pfizer moves to a non-profit model for drug sales in 45 lower-income countries https://ift.tt/rdAyBSK Zachary Brennan via Endpoints https://endpts.com May 25, 2022